Literature DB >> 8328548

Tobacco amblyopia.

J F Rizzo1, S Lessell.   

Abstract

Tobacco amblyopia, once an important cause of bilateral optic neuropathy, has become so rare in the United States that some investigators doubt its existence. However, we treated two men who appeared to have this disorder. These two patients demonstrate that tobacco amblyopia can develop without malnutrition, alcoholism, or disordered vitamin B12 metabolism. Both patients recovered, one with cessation of smoking and the other with intramuscular administration of hydroxocobalamin despite continued smoking.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8328548     DOI: 10.1016/s0002-9394(14)71749-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Acute effects of cigarette smoking on pattern electroretinogram.

Authors:  Fatih C Gundogan; A Hakan Durukan; Tarkan Mumcuoglu; Gungor Sobaci; M Zeki Bayraktar
Journal:  Doc Ophthalmol       Date:  2006-09-14       Impact factor: 2.379

2.  Leber hereditary optic neuropathy: bad habits, bad vision?

Authors:  Nancy J Newman
Journal:  Brain       Date:  2009-09       Impact factor: 13.501

3.  Knowledge about the relationship between smoking and blindness in Canada, the United States, the United Kingdom, and Australia: results from the International Tobacco Control Four-Country Project.

Authors:  Ryan David Kennedy; Marlee M Spafford; Carla M Parkinson; Geoffrey T Fong
Journal:  Optometry       Date:  2011-05

Review 4.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

5.  Clinical approach to optic neuropathies.

Authors:  Raed Behbehani
Journal:  Clin Ophthalmol       Date:  2007-09

6.  Toxic optic neuropathy.

Authors:  Pradeep Sharma; Reena Sharma
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.